An inducible signal 1 booster overcomes limited access to antigen for solid tumor cell therapy. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926001918?dgcid=rss_sd_all
An inducible signal 1 booster overcomes limited access to antigen for solid tumor cell therapy. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926001918?dgcid=rss_sd_all
“An inducible signal 1 booster overcomes limited access to antigen for solid tumor cell therapy.” Molecular Therapy: Oncology.
@article{article90279,
title = {An inducible signal 1 booster overcomes limited access to antigen for solid tumor cell therapy},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926001918?dgcid=rss_sd_all}
}